Purvish Parikh

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

Giorgio V. Scagliotti, Purvish Parikh, Joachim von Pawel et al. · Journal of Clinical Oncology · 2008 · 3.2K citations

Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer

Giorgio V. Scagliotti, Purvish Parikh, Joachim von Pawel et al. · Journal of Clinical Oncology · 2023 · 265 citations

Safety and Efficacy of Subcutaneous-Administered Omacetaxine Mepesuccinate in Chronic Myeloid Leukemia (CML) Patients Who Are Resistant or Intolerant to Two or More Tyrosine Kinase Inhibitors – Results of A Multicenter Phase 2/3 Study.

Jörge E. Cortes, Raghunadharao Digumarti, Purvish Parikh et al. · Blood · 2009 · 32 citations

A prospective, randomized double-blind trial comparing metoclopramide alone with metoclopramide plus dexamethasone in preventing emesis induced by high-dose cisplatin

Purvish Parikh, Bishan S. Charak, Shripad Banavali et al. · Cancer · 1988 · 26 citations

Therapeutic Drug Monitoring, Oncology, Randomized Double-blind Trial +11

Neoadjuvant chemotherapy or chemoradiotherapy in head and neck cancer

Preetesh Jain, Prabhash Kumar, VasanthRaghuvir Pai et al. · Indian Journal of Cancer · 2008 · 19 citations

Surgical Oncology, Neck Cancer, Neoadjuvant Therapy +18